Table 3.
Association between pan-immune-inflammation value (PIV) and cardiovascular disease (CVD) mortality (Fine–Gray competing risk model).
Model 1 |
Model 2 |
Model 3 |
||||
---|---|---|---|---|---|---|
SHR (95% CI) | p-value | SHR (95% CI) | p-value | SHR (95% CI) | p-value | |
Tertile 1 | Reference | Reference | Reference | |||
Tertile 2 | 1.64 (1.22–2.17) | 0.001 | 1.58 (1.17–2.23) | 0.003 | 1.84 (1.30–2.59) | <0.001 |
Tertile 3 | 1.93 (1.44–2.59) | <0.001 | 1.73 (1.27–2.35) | <0.001 | 1.99 (1.40–2.83) | <0.001 |
Model 1: no covariates were adjusted.
Model 2: was adjusted for age, gender, smoking, history of medication, history of cardiovascular diseae, hypertension and diabetes.
Model 3: was adjusted for Model 2 + clinic factors (body mass index, hemoglobin, albumin, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, C-reactive protein, calcium, phosphate, intact parathyroid hormone and estimated glomerular filtration rate).